
Clinical Data from DAFFODIL™ Study on DAYBUE® (trofinetide) in Rett Syndrome Published
DAFFODIL™ Study Results Highlight Long-Term Safety and Efficacy of DAYBUE® (Trofinetide) in Younger Patients with Rett Syndrome Acadia Pharmaceuticals Inc. has announced the publication of results from the open-label DAFFODIL™ study in the journal Med. The study evaluated the long-term…











